-
1
-
2
-
3
-
4
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unre...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
5